Clinical Trials
113 trialsRemoval of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
National Institutes of Health Clinical Center (CC)
Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies
National Institutes of Health Clinical Center (CC)
BASECAMP-1
A2 Biotherapeutics Inc.
Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer
National Institutes of Health Clinical Center (CC)
DESCENT-1
A2 Biotherapeutics Inc.
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
Stanford University
National Cancer Institute "Cancer Moonshot Biobank"
National Cancer Institute (NCI)
LONGEVITI
University of Alberta
iCaRe2
University of Nebraska
REFLECT
University Health Network, Toronto
GYNECO-IMM&CO
Centre Leon Berard
CER
Cancer Support Community, Research and Training Institute, Philadelphia
A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian Cancer
Peking University Third Hospital
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
National Institutes of Health Clinical Center (CC)
TraveraRTGx
Travera Inc
ASAP
Avera McKennan Hospital & University Health Center
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
Wake Forest University Health Sciences
PRO-ACTIVE
Fondazione del Piemonte per l'Oncologia
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
Carevive Systems, Inc.
EXoPERT EMERALD Clinical Study
EXoPERT
CAMPERR
Adela, Inc
SCORE
Natera, Inc.
Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers
Memorial Sloan Kettering Cancer Center
LIBERATE
University Health Network, Toronto
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
Assessing the Time Demands of Cancer
Masonic Cancer Center, University of Minnesota
COSMOS
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
OLAP
AstraZeneca
Clinical Significance of Germline BRCA Mutations
Memorial Sloan Kettering Cancer Center
PRIORITY
Institut Bergonié
START
Lyell Immunopharma, Inc.
Assessment of Paclitaxel-Induced Neuropathy
University of Chicago
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
Improved Early Diagnosis in Female Pelvic Cancer With OC Detect
Region Skane
PREFER
Labcorp Corporation of America Holdings, Inc
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Northwestern University
INSPIRE
Singlera Genomics Inc.
MOHCCN-O
University Health Network, Toronto
Evaluating Efficacy and Tolerability of Anticancer Drug Therapies for the Treatment of Gynecologic and Breast Cancers
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
MiraKind
ROOT
Taproot Health
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Travera Inc
QUANTUM
VitaMed Research LLC
A-TRAIN
National Cancer Center, Japan
Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199
GOG Foundation
Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives
M.D. Anderson Cancer Center
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Sanguine Biosciences
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Beijing Friendship Hospital
STILVARCA
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
A Study Of TeleGenetics Versus Usual Care To Increase Access To Cancer Genetic Services
Abramson Cancer Center at Penn Medicine